目的 观察肠胃康治疗溃疡性结肠炎的疗效及不良反应.方法 选取溃疡性结肠炎患者60例,分为柳氮磺嘧啶组与柳氮磺嘧啶治疗基础上联合肠胃康治疗组(肠胃康组)两组,统计分析两组患者的临床症状及临床疗效.结果 和治疗前相比,两组患者治疗后的腹痛、腹泻、脘腹胀满、食少、苔黄腻、粘液便、脓血便、肢体倦怠存在率均显著降低(P＜0.05);治疗后和柳氮磺嘧啶组相比,肠胃康组患者的腹痛、腹泻、脘腹胀满、食少、苔黄腻、粘液便、脓血便、肢体倦怠存在率均显著降低(P＜0.05);肠胃康组患者治疗的总有效率显著高于柳氮磺嘧啶组(P＜0.05).结论 肠胃康治疗溃疡性结肠炎的疗效显著,值得临床推广.“,”Objective To analyze the efficacy and adverse reactions of Changwei Kang in treatment of ulcerative colitis. Methods 60 cases of patients with ulcerative colitis were randomly divided into two groups,sulfasalazine treatment group was treated with sulfasalazine,on the basis of which Changwei Kang group was treated with Changwei Kang. The clinical symptoms and clinical efficacy of the two groups were statistically analyzed. Results Compared with before treatment,the incidences of abdominal pain,diarrhea,fullness of abdomen,less food,yellow greasy fur,mucous stool,pus and blood stool, limb burnout after treatment of the two groups were significantly lower (P＜0.05); compared with sulfadiazine treatment group, the incidences of the above syptoms of Changwei Kang group was significantly lower (P＜0.05). The total effective rate of Changwei Kang group was significantly higher than that of sulfasalazine treatment group (P＜0.05). Conclusion Changwei Kang is effective in treatment of ulcerative colitis, it is worthy of clinical promotion.